Sphingolipids and insulin resistance: the five Ws
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Inhibition of sphingolipid synthesis increases insulin sensitivity, resolves hepatic steatosis, and prevents the onset of diabetes in obese rodents. I herein review these interventional studies, aiming to summarize the five Ws - the 'Who, What, Where, When, and Why' questions that need to be addressed to understand roles of sphingolipids in the pathogenesis of diabetes. RECENT FINDINGS: Who: ceramides and glucosylceramides are likely to be independent antagonists of insulin action. Where: recent data suggest that ceramides may inhibit insulin action in skeletal muscle, whereas glucosylceramides may be more efficacious in adipose tissue. In contrast, sphingolipid accumulation in the liver appears to be insufficient to induce insulin resistance. What: ceramides and glucosylceramides inhibit different insulin signaling events, but it is unclear whether these actions account for the broad spectrum of therapeutic benefits resulting from sphingolipid depletion. When: recent data suggest that obesity-induced inflammation is important for the induction of sphingolipid synthesis. Why: sphingolipids have an evolutionarily conserved role to starve cells of nutrients, and the inhibition of insulin action is possibly a component of this broader action. SUMMARY: Despite considerable attention to the question of how sphingolipids induce metabolic disease, there exist enormous gaps in knowledge. Further elucidation of these molecular details will be essential for the development of new therapeutic strategies for inhibiting sphingolipid action and ameliorating metabolic diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ceramides have been linked to hepatic IR, and they inhibit several mediators of the insulin signalling pathway, such as insulin receptor substrate 1, phosphatidylinositol 3-kinase, and Akt.118”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [118]
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274
RetractedCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Self-citationThe Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200008200 · Cited by 907
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Self-citationDe Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway
Merrill, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200009200 · Cited by 617
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Self-citationDistinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function
Maedler, K., Spinas, G. A., Dyntar, D., Moritz, W., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.1.69 · Cited by 552
Insulin resistance is a cellular antioxidant defense mechanism
Hoehn, K. L., Salmon, A. B., Hohnen-Behrens, C., Turner, N., Hoy, A. J., Maghzal, G. J., Stocker, R., Van Remmen, H., Kraegen, E. W., Cooney, G. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902380106 · Cited by 540
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver
Monetti, M., Levin, M. C., Watt, M. J., Sajan, M. P., Marmor, S., Hubbard, B. K., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.005 · Cited by 511
Chavez, J. A., & Summers, S. A. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.020 · Cited by 498
Self-citationSummers, S. A., Garza, L. A., Zhou, H., & Birnbaum, M. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5457 · Cited by 475
Self-citationCeramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 411
Lipoapoptosis in Beta-cells of Obese Prediabeticfa/fa Rats
Shimabukuro, M., Higa, M., Zhou, Y.-T., Wang, M.-Y., Newgard, C. B., & Unger, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32487 · Cited by 395
Kabayama, K., Sato, T., Saito, K., Loberto, N., Prinetti, A., Sonnino, S., Kinjo, M., Igarashi, Y., & Inokuchi, J.-I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703650104 · Cited by 388
Powell, D. J., Hajduch, E., Kular, G., & Hundal, H. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7794-7808.2003 · Cited by 370
Liu, L., Zhang, Y., Chen, N., Shi, X., Tsang, B., & Yu, Y.-H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30565 · Cited by 356
Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103705200 · Cited by 355
Cohen, A. W., Razani, B., Wang, X. B., Combs, T. P., Williams, T. M., Scherer, P. E., & Lisanti, M. P. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00006.2003 · Cited by 351
Zhou, H., Summers, S. A., Birnbaum, M. J., & Pittman, R. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16568 · Cited by 347
Self-citationIRS1-Independent Defects Define Major Nodes of Insulin Resistance
Hoehn, K. L., Hohnen-Behrens, C., Cederberg, A., Wu, L. E., Turner, N., Yuasa, T., Ebina, Y., & James, D. E. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.005 · Cited by 320
Kolak, M., Westerbacka, J., Velagapudi, V. R., Wågsäter, D., Yetukuri, L., Makkonen, J., Rissanen, A., Häkkinen, A.-M., Lindell, M., Bergholm, R., et al. (2007) · Diabetes · doi:10.2337/db07-0111 · Cited by 317
Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity
Aerts, J. M., Ottenhoff, R., Powlson, A. S., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J., Wennekes, T., et al. (2007) · Diabetes · doi:10.2337/db06-1619 · Cited by 301
Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice
Hojjati, M. R., Li, Z., Zhou, H., Tang, S., Huan, C., Ooi, E., Lu, S., & Jiang, X.-C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412348200 · Cited by 299
Yang, G., Badeanlou, L., Bielawski, J., Roberts, A. J., Hannun, Y. A., & Samad, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91014.2008 · Cited by 295
Sphingolipids in inflammation: pathological implications and potential therapeutic targets
Nixon, G. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00281.x · Cited by 285
Altered Adipose and Plasma Sphingolipid Metabolism in Obesity
Samad, F., Hester, K. D., Yang, G., Hannun, Y. A., & Bielawski, J. (2006) · Diabetes · doi:10.2337/db06-0330 · Cited by 279
Ceramide Inhibits Protein Kinase B/Akt by Promoting Dephosphorylation of Serine 473
Schubert, K. M., Scheid, M. P., & Duronio, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13330 · Cited by 277
1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo.
Turinsky, J., O'Sullivan, D. M., & Bayly, B. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44844-7 · Cited by 269
POWELL, D. J., TURBAN, S., GRAY, A., HAJDUCH, E., & HUNDAL, H. S. (2004) · Biochemical Journal · doi:10.1042/bj20040139 · Cited by 267
Yetukuri, L., Katajamaa, M., Medina-Gomez, G., Seppänen-Laakso, T., Vidal-Puig, A., & Orešič, M. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-12 · Cited by 263
Kotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245
Kelpe, C. L., Moore, P. C., Parazzoli, S. D., Wicksteed, B., Rhodes, C. J., & Poitout, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302548200 · Cited by 238
Zhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Siegel, C., Komarnitsky, S., Yew, N. S., & Cheng, S. H. (2007) · Diabetes · doi:10.2337/db06-0719 · Cited by 238
Hajduch, E., Balendran, A., Batty, I. H., Litherland, G. J., Blair, A. S., Downes, C. P., & Hundal, H. S. (2001) · Diabetologia · doi:10.1007/s001250051596 · Cited by 235
Coen, P. M., Dubé, J. J., Amati, F., Stefanovic-Racic, M., Ferrell, R. E., Toledo, F. G. S., & Goodpaster, B. H. (2010) · Diabetes · doi:10.2337/db09-0988 · Cited by 230
Teruel, T., Hernandez, R., & Lorenzo, M. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2563 · Cited by 230
Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice
Park, T.-S., Panek, R. L., Mueller, S. B., Hanselman, J. C., Rosebury, W. S., Robertson, A. W., Kindt, E. K., Homan, R., Karathanasis, S. K., & Rekhter, M. D. (2004) · Circulation · doi:10.1161/01.cir.0000148370.60535.22 · Cited by 223
Chavez, J. A., Holland, W. L., Bär, J., Sandhoff, K., & Summers, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412769200 · Cited by 219
Self-citationJeBailey, L., Wanono, O., Niu, W., Roessler, J., Rudich, A., & Klip, A. (2007) · Diabetes · doi:10.2337/db06-0823 · Cited by 209
Salinas, M., López-Valdaliso, R., Martı́n, D., Alvarez, A., & Cuadrado, A. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0813 · Cited by 199
Ceramide starves cells to death by downregulating nutrient transporter proteins
Guenther, G. G., Peralta, E. R., Rosales, K. R., Wong, S. Y., Siskind, L. J., & Edinger, A. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802781105 · Cited by 195
de Mello, V. D. F., Lankinen, M., Schwab, U., Kolehmainen, M., Lehto, S., Seppänen-Laakso, T., Orešič, M., Pulkkinen, L., Uusitupa, M., & Erkkilä, A. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1482-9 · Cited by 181
Minehira, K., Young, S. G., Villanueva, C. J., Yetukuri, L., Oresic, M., Hellerstein, M. K., Farese, R. V., Horton, J. D., Preitner, F., Thorens, B., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800248-jlr200 · Cited by 164
Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation
STRATFORD, S., DEWALD, D. B., & SUMMERS, S. A. (2001) · Biochemical Journal · doi:10.1042/bj3540359 · Cited by 161
Self-citationKey Role for Ceramides in Mediating Insulin Resistance in Human Muscle Cells
Pickersgill, L., Litherland, G. J., Greenberg, A. S., Walker, M., & Yeaman, S. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611157200 · Cited by 146
Resjö, S., Göransson, O., Härndahl, L., Zołnierowicz, S., Manganiello, V. C., & Degerman, E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00238-8 · Cited by 144
LONG, S. D., & PEKALA, P. H. (1996) · Biochemical Journal · doi:10.1042/bj3190179 · Cited by 125
van Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seeman, I., Ghauharali-van der Vlugt, K., Overkleeft, H. S., Arbeeny, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004723 · Cited by 112
Phytosphingosine as a Specific Inhibitor of Growth and Nutrient Import in Saccharomyces cerevisiae
Chung, N., Mao, C., Heitman, J., Hannun, Y. A., & Obeid, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105653200 · Cited by 105
Bijl, N., Sokolović, M., Vrins, C., Langeveld, M., Moerland, P. D., Ottenhoff, R., van Roomen, C. P. A. A., Claessen, N., Boot, R. G., Aten, J., et al. (2009) · Hepatology · doi:10.1002/hep.23175 · Cited by 92
Deevska, G. M., Rozenova, K. A., Giltiay, N. V., Chambers, M. A., White, J., Boyanovsky, B. B., Wei, J., Daugherty, A., Smart, E. J., Reid, M. B., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807800200 · Cited by 91
Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #
Zhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Maniatis, P., Pacheco, J., Piepenhagen, P., Copeland, D., Arbeeny, C., Shayman, J. A., et al. (2009) · Hepatology · doi:10.1002/hep.22970 · Cited by 88
Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance
Langeveld, M., Ghauharali, K. J. M., Sauerwein, H. P., Ackermans, M. T., Groener, J. E. M., Hollak, C. E. M., Aerts, J. M., & Serlie, M. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1702 · Cited by 82
Zinda, M. J., Vlahos, C. J., & Lai, M. T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4248 · Cited by 80
Skrzypek, M., Lester, R. L., & Dickson, R. C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.5.1513-1520.1997 · Cited by 76
Fontés, G., Semache, M., Hagman, D. K., Tremblay, C., Shah, R., Rhodes, C. J., Rutter, J., & Poitout, V. (2009) · Diabetes · doi:10.2337/db08-0579 · Cited by 59
Veluthakal, R., Palanivel, R., Zhao, Y., McDonald, P. J., Gruber, S. A., & Kowluru, A. (2005) · APOPTOSIS · doi:10.1007/s10495-005-0431-4 · Cited by 58
Todd, M. K., Watt, M. J., Le, J., Hevener, A. L., & Turcotte, L. P. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00080.2006 · Cited by 58
Ceramide: a contributor to insulin resistance or an innocent bystander?
Boden, G. (2008) · Diabetologia · doi:10.1007/s00125-008-1015-y · Cited by 43
The Role of Skeletal Muscle Sphingolipids in the Development of Insulin Resistance
Straczkowski, M., & Kowalska, I. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.13 · Cited by 41
A new take on ceramide: Starving cells by cutting off the nutrient supply
Guenther, G., & Edinger, A. L. (2009) · Cell Cycle · doi:10.4161/cc.8.8.8161 · Cited by 32
Xie, X., Chen, Z.-X., Lei, M., He, X., Schuchman, E. H., Feng, L., Xu, H., & An-Hua, L. (2009) · PubMed · Cited by 30
Mogami, K., Kishi, H., & Kobayashi, S. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.100 · Cited by 29
Glaros, E. N., Kim, W. S., Rye, K.-A., Shayman, J. A., & Garner, B. (2008) · Journal of Lipid Research · doi:10.1194/jlr.e800005-jlr200 · Cited by 28
Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles.
Zendzian-Piotrowska, M., Baranowski, M., Zabielski, P., & Górski, J. (2006) · PubMed · Cited by 25
Zhang, Y., Ranta, F., Tang, C., Shumilina, E. V., Mahmud, H., Föller, M., Ullrich, S., Häring, H., & Lang, F. J. W. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0364-4 · Cited by 24
Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice #
Bijl, N., van Roomen, C. P. A. A., Triantis, V., Sokolović, M., Ottenhoff, R., Scheij, S. S., van Eijk, M., Boot, R. G., Aerts, J. M. F. G., & Groen, A. K. (2008) · Hepatology · doi:10.1002/hep.22663 · Cited by 23
Acute activation of acid ceramidase affects cytokine‐induced cytotoxicity in rat islet β‐cells
Zhu, Q., Shan, X., Miao, H., Lu, Y., Xu, J., Na, Y., Liu, C., Liao, D., & Jin, J. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.047 · Cited by 22
Bijl, N., Scheij, S. S., Houten, S. M., Boot, R. G., Groen, A. K., & Aerts, J. M. F. G. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139394 · Cited by 19
Cited by
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Inflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,132
Sphingosine-1-phosphate signaling and its role in disease
Maceyka, M., Harikumar, K. B., Milstien, S., & Spiegel, S. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.003 · Cited by 1,039
Metadata
- Authors
- Summers, S. A.
- Affiliations
- National University of Singapore (SG)
- Corresponding author
- Summers, Scott A
- ORCID
- Summers, Scott A
- Venue
- Current Opinion in Lipidology
- Published
- 2010-04
- Volume
- 21
- Issue
- 2
- Pages
- 128-135
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2023794522
- Cited by
- 136
- References
- 73
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 11 · 2016: 7 · 2015: 9 · 2014: 11 · 2013: 9 · 2012: 22
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK081456, R01DK081456)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- sphingolipids, insulin resistance, ceramide, glucosylceramide, hepatic steatosis, obesity, diabetes mellitus, skeletal muscle insulin signaling, adipose tissue, obesity-associated inflammation, metabolic disorders, nutrient deprivation
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Obesity, Sphingolipids, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.